Laboratorios Farmaceuticos Rovi (ES:ROVI) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Laboratorios Farmacéuticos ROVI, S.A. has successfully completed a share capital reduction by redeeming 2,780,395 of its own shares, resulting in a new share capital total of 3,074,145.72 euros. This adjustment, effective from September 13, 2024, has led to an automatic increase in the remaining shareholders’ percentage of ownership. The operation was in line with decisions from the General Shareholders’ Meeting and has led to the amendment of the company’s corporate bylaws regarding share capital structure.
For further insights into ES:ROVI stock, check out TipRanks’ Stock Analysis page.